Co-Authors
This is a "connection" page, showing publications co-authored by Ronan Roussel and Louis Potier.
Connection Strength
4.848
-
Stay-at-Home Orders During the COVID-19 Pandemic, an Opportunity to Improve Glucose Control Through Behavioral Changes in Type 1 Diabetes. Diabetes Care. 2021 03; 44(3):839-843.
Score: 0.920
-
Letter by Potier and Roussel Regarding Article, "Are We Ready to Bell the Cat? A Call for Cardiologists to Embrace Glucose-Lowering Therapies Proven to Improve Cardiovascular Outcomes". Circulation. 2019 01 08; 139(2):303-304.
Score: 0.803
-
Prevention of cardiovascular disease through reduction of glycaemic exposure in type 2 diabetes: A perspective on glucose-lowering interventions. Diabetes Obes Metab. 2018 02; 20(2):238-244.
Score: 0.726
-
Response to Letter to the Editor From Woolcott and Castilla-Bancayán: "Diabetes Increases Severe COVID-19 Outcomes Primarily in Younger Adults". J Clin Endocrinol Metab. 2021 11 19; 106(12):e5277-e5278.
Score: 0.245
-
The COVID-19 lockdown as an opportunity to change lifestyle and body weight in people with overweight/obesity and diabetes: Results from the national French COVIDIAB cohort. Nutr Metab Cardiovasc Dis. 2021 08 26; 31(9):2605-2611.
Score: 0.238
-
Diabetes Increases Severe COVID-19 Outcomes Primarily in Younger Adults. J Clin Endocrinol Metab. 2021 08 18; 106(9):e3364-e3368.
Score: 0.237
-
COVID-19 symptoms masking inaugural ketoacidosis of type 1 diabetes. Diabetes Metab. 2021 02; 47(1):101162.
Score: 0.221
-
Plasma copeptin, kidney disease, and risk for cardiovascular morbidity and mortality in two cohorts of type 2 diabetes. Cardiovasc Diabetol. 2018 08 02; 17(1):110.
Score: 0.195
-
Non-severe hypoglycaemia is associated with weight gain in patients with type 1 diabetes: Results from the Diabetes Control and Complication Trial. Diabetes Obes Metab. 2018 05; 20(5):1289-1292.
Score: 0.188
-
Relationship between cardiac microvascular dysfunction measured with 82Rubidium-PET and albuminuria in patients with diabetes mellitus. Cardiovasc Diabetol. 2018 01 11; 17(1):11.
Score: 0.187
-
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in high vascular risk. Heart. 2017 09; 103(17):1339-1346.
Score: 0.177
-
Predicting severe hypoglycaemia with self-monitoring of blood glucose in type 1 diabetes. Diabetes Metab. 2017 09; 43(4):392-394.
Score: 0.176
-
Predictors of hospital discharge and mortality in patients with diabetes and COVID-19: updated results from the nationwide CORONADO study. Diabetologia. 2021 04; 64(4):778-794.
Score: 0.058
-
Association of diabetes and outcomes in patients with COVID-19: Propensity score-matched analyses from a French retrospective cohort. Diabetes Metab. 2021 07; 47(4):101222.
Score: 0.058
-
Monocytopenia, monocyte morphological anomalies and hyperinflammation characterise severe COVID-19 in type 2 diabetes. EMBO Mol Med. 2020 10 07; 12(10):e13038.
Score: 0.056
-
Correction to: Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study. Diabetologia. 2020 09; 63(9):1953-1957.
Score: 0.056
-
Blood glucose levels and COVID-19. Reply to Sardu C, D'Onofrio N, Balestrieri ML et al [letter] and Lepper PM, Bals R, Jüni P et al [letter]. Diabetologia. 2020 11; 63(11):2491-2494.
Score: 0.056
-
Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study. Diabetologia. 2020 08; 63(8):1500-1515.
Score: 0.055
-
Head-to-head comparison of the diagnostic performances of Rubidium-PET and SPECT with CZT camera for the detection of myocardial ischemia in a population of women and overweight individuals. J Nucl Cardiol. 2020 06; 27(3):755-768.
Score: 0.050
-
Lower extremity arterial disease in patients with diabetes: a contemporary narrative review. Cardiovasc Diabetol. 2018 10 23; 17(1):138.
Score: 0.049
-
Prognostic Values of Inflammatory and Redox Status Biomarkers on the Risk of Major Lower-Extremity Artery Disease in Individuals With Type 2 Diabetes. Diabetes Care. 2018 10; 41(10):2162-2169.
Score: 0.049
-
Plasma proprotein-convertase-subtilisin/kexin type 9 (PCSK9) and cardiovascular events in type 2 diabetes. Diabetes Obes Metab. 2018 04; 20(4):943-953.
Score: 0.047